Swarajya
Our View
Headlines
Magazine
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Podcasts
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Podcasts
Archives
Blogs
News Brief
Lancet
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In Lancet
Swarajya Staff
Nov 12, 2021 10:05 AM +05:30 IST
Serum Institute's Chairman Cyrus Poonawalla Bats For Booster Dose Of Covishield After Six Months
Swarajya Staff
Aug 14, 2021 12:27 PM +05:30 IST
Pfizer COVID-19 Vaccine Produces Less Antibodies Against Delta Variant Of Coronavirus, Finds Study Published In Lancet
IANS
Jun 4, 2021 02:38 PM +05:30 IST
Tracing The Origin Question Of Coronavirus And Associated Controversies
Alok Bhatt
May 21, 2021 08:00 PM +05:30 IST
Covid-19 Origins And Obfuscations: Those Who Preach About Keeping 'Science At Heart' Must Follow Their Own Advice
Sujeet Mishra
May 17, 2021 11:04 AM +05:30 IST
Bharat Biotech Covaxin Safe, Generates Immune Response Against COVID-19: Study Published In British Medical Journal Lancet
Swarajya Staff
Jan 22, 2021 05:28 PM +05:30 IST
Sputnik V: Russian Covid-19 Vaccine Developers Respond To Criticism Of Clinical Trial Data In Medical Journal Lancet
Swarajya Staff
Sep 19, 2020 12:58 PM +05:30 IST
Coronavirus: Triple Drug Antiviral Therapy Shows Promise For Treating Covid-19 Patients In Clinical Trial
IANS
May 9, 2020 02:04 PM +05:30 IST
India Gains Four Spots In Global Human Capital Rankings By Institute for Health Metrics and Evaluation
Swarajya Staff
Sep 26, 2018 10:41 AM +05:30 IST
Load More